Following lower-than-expected profits, Evotec plans to cut costs, completes CEO search

Evotec an­nounced a “re­set” to its busi­ness plan as it re­port­ed fi­nan­cial re­sults Wednes­day, fol­low­ing a year in which many con­tract drug man­u­fac­tur­ers have strug­gled.

The Ger­man com­pa­ny al­so an­nounced that Chris­t­ian Wo­jczews­ki will join as its new CEO at the start of Ju­ly. Wo­jczews­ki, who was pre­vi­ous­ly the CEO of Dutch health­care com­pa­ny Mediq, will re­place Evotec’s in­ter­im leader Mario Poly­wka. Poly­wka served as Evotec’s chief op­er­at­ing of­fi­cer for 13 years un­til 2018, and took the in­ter­im CEO role in Jan­u­ary, when long­time Evotec head Wern­er Lan­thaler re­signed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.